Accuray: 93% of Low-risk Prostate Cancer Patients Disease-free 10 Years After CyberKnife Therapy

Accuray: 93% of Low-risk Prostate Cancer Patients Disease-free 10 Years After CyberKnife Therapy
More than 93 percent of men with low risk-prostate cancer treated with the CyberKnife System were still disease-free 10 years later, said the system’s manufacturer, Sunnyvale, California-based Accuray. A study detailing the treatment, “Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis,” appeared in the journal Cureus. CyberKnife edlivers stereotactic body radiation therapy (SBRT), a type of radiotherapy that uses

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Jeremy A says:

    I did not know about the Cyber Knife thing but it seems to be very effective, anyway, I am glad I did get over my prostate symptoms by taking a supplement named alpharise and maintaining a healthy lifestyle and a good alimentation. It works and has no side effects because its all natural.

Leave a Comment

Your email address will not be published. Required fields are marked *